Skip to content
CNS Clinical Research

San Francisco, California

CNS clinical trials in San Francisco, CA

53 CNS studies are recruiting participants at sites in San Francisco as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.

Call (888) 520-7418
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

San Francisco at a glance

  • 53 studies are recruiting at a site in San Francisco.
  • By phase: Early Phase 1 (2), Phase 1/2 (3), Phase 2 (6), Phase 3 (10), No phase (20), Observational (12). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (35), industry (17), government (1).
  • By research area: Depression (18), Parkinson's Disease (14), Multiple Sclerosis (8), Epilepsy (5), Migraine (3), Schizophrenia (3), ADHD (2).
  • Most recent update to one of these records: November 16, 2026.

Depression studies recruiting in San Francisco

Basic details from each study's public record (the 30 most recently updated of 53). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. E-Mindfulness Approaches for Living After Breast Cancer

    • Phase 3
    • Ages 18 to 50
    • All sexes
    Sponsor
    NRG Oncology
    Study site
    Kaiser Permanente-San Francisco
    Registry record
    NCT06748222 · updated
  2. Focused Ultrasound for Behavioral Health

    • No phase
    • Ages 22 to 80
    • All sexes
    Sponsor
    Attune Neurosciences Inc
    Study site
    Attune, San Francisco Clinical Research Center
    Registry record
    NCT07851038 · updated
  3. Understanding the Neural Underpinnings of Risk-Taking Behavior in Psychiatric Disease

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, San Francisco
    Registry record
    NCT07896343 · updated
  4. Near Infrared Spectroscopy (NIRS) for Assessment of Depression

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, San Francisco
    Study site
    San Francisco Veterans Affairs Medical Center
    Registry record
    NCT04061148 · updated
  5. NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Neurocrine Biosciences
    Study site
    Neurocrine Clinical Site
    Registry record
    NCT06911112 · updated
  6. Psilocybin Therapy for Depression in Parkinson's Disease

    • Phase 2
    • Ages 40 to 80
    • All sexes
    Sponsor
    Joshua Woolley, MD, PhD
    Study site
    University of California, San Francisco
    Registry record
    NCT06455293 · updated
  7. Closed-Loop Deep Brain Stimulation for Major Depression

    • No phase
    • Ages 22 to 70
    • All sexes
    Sponsor
    Andrew Krystal
    Study site
    University of California, San Francisco
    Registry record
    NCT04004169 · updated
  8. A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

    • Phase 2
    • Ages 18 to 64
    • All sexes
    Sponsor
    Syndeio Biosciences, Inc
    Study site
    Studyops Inc
    Registry record
    NCT07115329 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in San Francisco, CA on ClinicalTrials.gov.

Schizophrenia studies recruiting in San Francisco

  1. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

    • Phase 3
    • Ages 13 to 17
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    UCSF Neurosciences Clinical Research Unit (NCRU)
    Registry record
    NCT07288567 · updated
  2. A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

    • Phase 3
    • Ages 5 to 17
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    UCSF Neurosciences Clinical Research Unit (NCRU)
    Registry record
    NCT07424404 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in San Francisco, CA on ClinicalTrials.gov.

ADHD studies recruiting in San Francisco

  1. The Myelin Disorders Biorepository Project

    • Observational
    • All ages
    • All sexes
    Sponsor
    Children's Hospital of Philadelphia
    Study site
    UCSF Benioff Children's Hospital
    Registry record
    NCT03047369 · updated
  2. External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms

    • No phase
    • Ages 7 to 14
    • All sexes
    Sponsor
    University of California, San Francisco
    Study site
    UCSF Nancy Friend Pritzker Psychiatry Building
    Registry record
    NCT07214545 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in San Francisco, CA on ClinicalTrials.gov.

Parkinson's disease studies recruiting in San Francisco

  1. Deep Brain Stimulation (DBS) Retrospective Outcomes Study

    • Observational
    • All ages
    • All sexes
    Sponsor
    Boston Scientific Corporation
    Study site
    University of California, San Francisco
    Registry record
    NCT03664609 · updated
  2. A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0016)
    Registry record
    NCT06841354 · updated
  3. A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    UCSF Medical Center at Mission Bay ( Site 0178)
    Registry record
    NCT06623422 · updated
  4. A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

    • Phase 3
    • Ages 50 to 85
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    UCSF Weill Institute for Neurosciences
    Registry record
    NCT07174310 · updated
  5. Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    University of California, San Francisco
    Study site
    University of California San Francisco
    Registry record
    NCT07398157 · updated
  6. Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator

    • No phase
    • Ages 25 to 75
    • All sexes
    Sponsor
    University of California, San Francisco
    Study site
    University of California San Francisco
    Registry record
    NCT07682311 · updated
  7. Parkinson's Foundation PD GENEration Genetic Registry

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Parkinson's Foundation
    Study site
    University of California San Francisco (UCSF)
    Registry record
    NCT04994015 · updated
  8. Parkinson Progression Marker Initiative Online (PPMI Online)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Michael J. Fox Foundation for Parkinson's Research
    Study site
    UCSF Movement Disorders and Neuromodulation Center (MDNC)
    Registry record
    NCT05065060 · updated
  9. PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

    • Observational
    • Ages 30 and older
    • All sexes
    Sponsor
    Michael J. Fox Foundation for Parkinson's Research
    Study site
    University of California, San Francisco
    Registry record
    NCT04477785 · updated

Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in San Francisco, CA on ClinicalTrials.gov.

Multiple sclerosis (MS) studies recruiting in San Francisco

  1. Care in Multiple Sclerosis (MS)

    • Observational
    • Ages 18 to 29
    • All sexes
    Sponsor
    NYU Langone Health
    Study site
    University of California, San Francisco
    Registry record
    NCT07011914 · updated
  2. Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

    • Observational
    • Ages 18 to 64
    • Female participants
    Sponsor
    University of California, San Francisco
    Study site
    University of California-San Francisco
    Registry record
    NCT06940323 · updated

Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in San Francisco, CA on ClinicalTrials.gov.

Epilepsy studies recruiting in San Francisco

  1. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Rapport Therapeutics Inc.
    Registry record
    NCT07563881 · updated
  2. Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Neurona Therapeutics
    Study site
    University of California San Francisco
    Registry record
    NCT05135091 · updated
  3. A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Encoded Therapeutics
    Study site
    UCSF Benioff Children's Hospitals
    Registry record
    NCT05419492 · updated
  4. Brain Development Research Program

    • Observational
    • All ages
    • All sexes
    Sponsor
    University of California, San Francisco
    Study site
    University of California, San francisco
    Registry record
    NCT00305305 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in San Francisco, CA on ClinicalTrials.gov.

Migraine studies recruiting in San Francisco

  1. A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    TriGemX Bio, Inc.
    Study site
    Optimus Medical Group
    Registry record
    NCT07816367 · updated
  2. Responding With Evidence and Access for Childhood Headaches

    • No phase
    • Ages 10 to 17
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    University of California San Francisco
    Registry record
    NCT05889624 · updated
  3. Emgality for Migraine in Breastmilk

    • Observational
    • Ages 18 to 45
    • Female participants
    Sponsor
    University of California, San Francisco
    Study site
    University of California, San Francisco
    Registry record
    NCT06085144 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in San Francisco, CA on ClinicalTrials.gov.

Ask about studies near San Francisco

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in California

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 520-7418

or send a short form

How should we reach you?

Call